Lupin three senior executives to retire in 2 days Ruchika Sharma29 March 2025 12:15 PM ISTMumbai: Global pharmaceutical giant Lupin has announced the retirement of its three senior executives.Naresh Gupta, President – API Plus &...
Lupin awarded EcoVadis Silver Medal for sustainability excellence Ruchika Sharma21 March 2025 2:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has been awarded "Silver Medal" by EcoVadis for its outstanding sustainability...
Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine Ruchika Sharma17 March 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin unveils heart drug Rivaroxaban in US Ruchika Sharma8 March 2025 11:41 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of...
Lupin secures place in Prestigious S&P Global Sustainability Yearbook 2025 Ruchika Sharma2 March 2025 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced its inclusion in prestigious S&P Global Sustainability Yearbook 2025, for the second...
USFDA issues EIR for Lupin Somerset facility Ruchika Sharma22 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has issued the...
Lupin bags USFDA nod for Ipratropium Bromide Nasal Solution for rhinorrhea Ruchika Sharma11 Feb 2025 10:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Lupin bags tentative USFDA okay for generic HIV Medication Ruchika Sharma4 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
USFDA completes inspection of Lupin Somerset facility with no observations Ruchika Sharma3 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a Pre-Approval...
USFDA nod to Lupin Ipratropium Bromide Nasal Solution for runny nose Ruchika Sharma29 Jan 2025 3:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin, Avas unveil myotonia treatment NaMuscla in Italy Ruchika Sharma29 Jan 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited and Avas Pharmaceuticals SRL have announced the launch of Lupin's orphan drug NaMuscla (mexiletine) in...
Lupin receives USFDA approval for heart failure drug Ruchika Sharma24 Jan 2025 4:24 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration...
